Navamedic ASA (N1A.F)

2.6700 -0.0200 (-0.74%) At close: 09:15AM CEST

Navamedic ASA

Henrik Ibsensgate 100
Oslo 0255
Norway
47 67 11 25 40
https://www.navamedic.com

Sector(s): Healthcare
Industry: Medical Distribution
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Kathrine E. Gamborg Andreassen	Chief Executive Officer	435.16k	N/A	1966
Mr. Lars Hjarrand	Chief Financial Officer	279.27k	N/A	N/A
Tony Brejke	C.O.O.	N/A	N/A	N/A
Ms. Astrid J. Torgersen Bratvedt	Chief Scientific Officer	N/A	N/A	N/A
Mattias Von Hartmann	Marketing and Sales Director	N/A	N/A	N/A
Mr. Ole Henrik Eriksen	Chief Business Development Officer	N/A	N/A	1960

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Corporate Governance

Navamedic ASA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.